Research & Literature

Autoimmune polyglandular syndrome type 3 (APS-3) among patients with premature ovarian insufficiency (POI).

Szlendak-Sauer K, Jakubik D, Kunicki M, et al.

European journal of obstetrics, gynecology, and reproductive biology 2016; (203()):61-5.

[Endocrinology and interdisciplinary consultation in internal medicine : Illustrated using the example of polyglandular autoimmune syndrome].

Kahaly GJ, Zimmermann J, Hansen MP, et al.

Der Internist 2017; (58(4)):308-328 doi:10.1007/s00108-017-0201-8.

Epidemiological and clinical peculiarities of polyglandular syndrome type 3 in pediatric age.

Valenzise M, Aversa T, Saccomanno A, et al.

Italian journal of pediatrics 2017; (43(1)):69 doi:10.1186/s13052-017-0386-4.

Disease and treatment factors associated with lower quality of life scores in adults with multiple endocrine neoplasia type I.

Goswami S, Peipert BJ, Helenowski I, et al.

Surgery 2017; (162(6)):1270-1277 doi:10.1016/j.surg.2017.07.023.

Health-related quality of life in MEN1 patients compared with other chronic conditions and the United States general population.

Peipert BJ, Goswami S, Yount SE, Sturgeon C

Surgery 2018; (163(1)):205-211 doi:10.1016/j.surg.2017.04.030.

Association pernicious anemia and autoimmune polyendocrinopathy: a retrospective study.

Zulfiqar AA, Andres E

Journal of medicine and life 2017; (10(4)):250-253.

Adrenal crisis in a 14-year-old boy 12 years after hematopoietic stem cell transplantation.

Penger T, Albrecht A, Marx M, et al.

Endocrinology, diabetes & metabolism case reports 2018; (2018()).

Sex Alters the MHC Class I HLA-A Association With Polyglandular Autoimmunity.

Flesch BK, König J, Frommer L, et al.

The Journal of clinical endocrinology and metabolism 2019; (104(5)):1680-1686 doi:10.1210/jc.2018-01974.

Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019.

Pimentel-Nunes P, Libânio D, Marcos-Pinto R, et al.

Endoscopy 2019; (51(4)):365-388 doi:10.1055/a-0859-1883.

Chronic atrophic gastritis: Natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive Endoscopists [AIGO], the Italian Society of Digestive Endoscopy [SIED], the Italian Society of Gastroenterology [SIGE], and the Italian Society of Internal Medicine [SIMI].

Lahner E, Zagari RM, Zullo A, et al.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2019; (51(12)):1621-1632 doi:10.1016/j.dld.2019.09.016.

Human Leukocyte Antigen (HLA) Subtype-Dependent Development of Myasthenia Gravis, Type-1 Diabetes Mellitus, and Hashimoto Disease: A Case Report of Autoimmune Polyendocrine Syndrome Type 3.

Gobaru M, Ashida K, Yoshinobu S, et al.

The American journal of case reports 2019; (20()):1709-1714 doi:10.12659/AJCR.918996.

A girl with lethargy and severe electrolyte imbalance.

Lamens SS, Hjort MA

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 2020; (140(9)) doi:10.4045/tidsskr.19.0737.

The altered circadian pattern of basal insulin requirements - an early marker of autoimmune polyendocrine syndromes in type 1 diabetes mellitus.

Pallayova M, Breznoscakova D

Endocrine regulations 2020; (54(2)):126-132.

Case of autoimmune polyendocrine syndrome type 3 complicated with anti-N-methyl-D-aspartic acid-receptor encephalitis.

Kurozumi A, Okada Y, Nishio K, Tanaka Y

Journal of diabetes investigation 2021; (12(2)):290-292 doi:10.1111/jdi.13341.

Levothyroxine and insulin requirement in autoimmune polyglandular type 3 syndrome: a real-life study.

Guarnotta V, Pillitteri G, Gambino G, et al.

Journal of endocrinological investigation 2021; (44(7)):1387-1394 doi:10.1007/s40618-020-01421-3.

[The prevalence of newly diagnosed autoimmune diseases among patients with Graves' disease and autoimmune polyglandular syndrome of adults].

Troshina EA, Larina AA, Sheremeta MS, Malisheva NM

Terapevticheskii arkhiv 2020; (92(10)):9-14 doi:10.26442/00403660.2020.10.000737.

Hypoparathyroidism as the single major component for decades of autoimmune polyglandular syndrome type 1.

Lima Ferreira J, Simões de Carvalho F, Marques AP, Príncipe RM

Endocrinology, diabetes & metabolism case reports 2020; (2020()).

[An adult case of Hashimoto's thyroiditis accompanying pernicious anemia and subacute combined degeneration].

Shimozono K

Rinsho shinkeigaku = Clinical neurology 2021; (61(7)):461-465 doi:10.5692/clinicalneurol.cn-001551.

Superior Mesenteric Artery Syndrome Accompanied by Acute-onset Type 1 Diabetes Complicated with Graves' Disease.

Sue-Nagumo M, Matsumoto S, Yamada E, et al.

Internal medicine (Tokyo, Japan) 2022; (61(10)):1555-1560 doi:10.2169/internalmedicine.8364-21.

Severe weight loss in a hypothyroid patient as an acute presentation of autoimmune polyglandular syndrome type II.

Silajdzija E, Bliddal S, Borgwardt L, et al.

Hormones (Athens, Greece) 2022; (21(2)):317-322 doi:10.1007/s42000-021-00344-9.

Pernicious Anemia: The Hematological Presentation of a Multifaceted Disorder Caused by Cobalamin Deficiency.

Esposito G, Dottori L, Pivetta G, et al.

Nutrients 2022; (14(8)) doi:10.3390/nu14081672.

Type-1 Grade 2 Multi-Focal Gastric Neuroendocrine Tumors Secondary to Chronic Autoimmune Gastritis.

Yu Z, Wang A, Hu C, et al.

Frontiers in medicine 2022; (9()):856125 doi:10.3389/fmed.2022.856125.

Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy.

Betterle C, Furmaniak J, Sabbadin C, et al.

Journal of endocrinological investigation 2023; (46(4)):643-665 doi:10.1007/s40618-022-01994-1.

Autoimmune polyendocrine syndromes associated with autoimmune rheumatic diseases.

Jankowska K, Dudek P, Stasiek M, Suchta K

Reumatologia 2023; (61(4)):225-238 doi:10.5114/reum/170266.

APECED and the place of AIRE in the puzzle of the immune network associated with autoimmunity.

Aytekin ES, Cagdas D

Scandinavian journal of immunology 2023; (98(2)):e13299 doi:10.1111/sji.13299.

Increased frequency of microalbuminuria in patients with type 3 autoimmune polyglandular syndrome (APS) compared to isolated autoimmune type 1 diabetes mellitus: A real-life study.

Radellini S, Vigneri E, Ferreri O, et al.

Diabetes research and clinical practice 2024; (213()):111746 doi:10.1016/j.diabres.2024.111746.

Iron and ferritin deficiency in women with hypothyroidism and chronic lymphocytic thyroiditis - systematic review.

Gierach M, Rudewicz M, Junik R

Endokrynologia Polska 2024; (75(3)):253-261 doi:10.5603/ep.97860.

Non-Invasive Markers for the Detection of Gastric Precancerous Conditions.

Romańczyk M, Osmola M, Link A, et al.

Cancers 2024; (16(12)) doi:10.3390/cancers16122254.

Severe Symptomatic Anemia as a Rare Initial Manifestation of Type 3 Polyglandular Autoimmune Syndrome: A Case Report.

Goncalves H, De Oliveira Simões F, Sá R, et al.

Cureus 2024; (16(12)):e75800 doi:10.7759/cureus.75800.

A case-control study on autoimmune polyendocrine syndromes in patients with systemic lupus erythematosus.

Piovani E, Gozzoli GI, Della Pina SEL, et al.

Rheumatology (Oxford, England) 2025; (64(11)):5656-5664 doi:10.1093/rheumatology/keaf320.

Autoimmune Polyglandular Syndrome Type 3b: A Key to Diagnosing Autoimmune Gastritis and Asymptomatic Primary Biliary Cholangitis.

Mabuchi S, Mabuchi H, Watari T

European journal of case reports in internal medicine 2025; (12(6)):005376 doi:10.12890/2025_005376.

Clinical and serological characteristics of type 3 APS, isolated T1DM and LADY/LADA.

Qiu Y, Guo L, Pan H, et al.

BMC endocrine disorders 2025; (25(1)):155 doi:10.1186/s12902-025-01969-2.

Autoimmune Polyglandular Syndrome Type 3 and Overlapping Autoimmune Endocrinopathies: A Case Report.

Nagarajan DR, Mani Jacob D, Ottu Para NK

Cureus 2025; (17(7)):e88574 doi:10.7759/cureus.88574.

Diabetic Ketoacidosis Associated With Painless Thyroiditis in a Patient Treated With an SGLT2 Inhibitor.

Aotani R, Ohkuma T, Oshiro A, et al.

Case reports in endocrinology 2025; (2025()):8872854 doi:10.1155/crie/8872854.

Intramuscular Cyanocobalamin Treatment in Patients with Corpus Atrophic Gastritis and Vitamin B12 Deficiency: Efficacy and Predictors of Increased Requirement-A Monocentric Longitudinal Real-Life Cohort Study.

Schiavone FP, Pivetta G, Scalamonti S, et al.

Nutrients 2026; (18(2)) doi:10.3390/nu18020271.

The "polyglandular crisis" behind recurrent hyponatremia: misdiagnosis of a case of autoimmune polyglandular syndrome type 2 and clinical lessons learned.

Yan M, Wu H, Deng J, et al.

Frontiers in immunology 2026; (17()):1744295 doi:10.3389/fimmu.2026.1744295.